Peter Finan

Title: **Innovator Profile: Peter Finan, Leading the Charge in Pharmaceutical Advancements**

Introduction

Peter Finan, a distinguished inventor based in Horsham, GB, has made significant contributions to the field of pharmaceuticals with a focus on innovative compounds for treating various diseases. With a commendable portfolio of three patents, Finan exemplifies the essence of innovation in medical research.

Latest Patents

Among Peter Finan's noteworthy inventions are his latest patents that showcase his expertise in the development of compounds targeting critical biological pathways. The first patent, titled "Imidazoquinolines as dual lipid kinase and mTOR inhibitors," pertains to the application of specific compounds in the treatment of diseases dependent on mammalian target of rapamycin (mTOR) kinase. This invention provides methods for using these compounds in therapeutic settings, particularly for human patients, as well as details about pharmaceutical preparations containing these compounds.

The second patent, "5-phenylthiazole derivatives and use as PI3 kinase inhibitors," involves compounds effective in treating diseases mediated by phosphatidylinositol 3-kinase. This patent outlines the preparation processes for these compounds and the pharmaceutical compositions that utilize them, demonstrating Finan's commitment to advancing medical treatments.

Career Highlights

Currently, Peter Finan is affiliated with Novartis AG, a global healthcare company renowned for its research and innovation in pharmaceuticals. His work predominantly revolves around the development of novel therapeutic agents, underscoring his contributions to the life sciences sector. Finan's patents illustrate his ability to bridge the gap between scientific research and practical medical applications.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues in the industry, including Ian Bruce and Clive McCarthy. These partnerships exemplify a collaborative spirit that is essential in driving forward pharmaceutical innovations and advancing the boundaries of research.

Conclusion

In conclusion, Peter Finan represents a vital force in the realm of pharmaceuticals, with a robust patent portfolio that reflects his innovative spirit and dedication to improving human health. His work at Novartis AG, alongside esteemed colleagues, positions him as a key contributor to ongoing advancements in medical treatments, ensuring that his inventions will continue to impact patients positively.